Clinical trial
Heart Failure With Reduced Ejection Fraction Polypill in Sri Lanka: A Multi-Center Type I Hybrid Randomized Controlled Trial
NCT07569640 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heart Failure With Reduced Ejection Fraction Polypill in Sri Lanka: A Multi-Center Type I Hybrid Randomized Controlled Trial
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 17, 2026
- Completion date
- April 30, 2029
- Enrollment
- 1,672 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure with reduced ejection fraction